Expertise in
25
conditions

Dr. Jeffrey Carlin

Rheumatology
Virginia Mason Medical Center
1100 9th Ave, 
Seattle, WA 
Offers Telehealth
Expertise in
25
conditions
Virginia Mason Medical Center
1100 9th Ave, 
Seattle, WA 

Overview

Jeffrey Carlin is a Rheumatologist in Seattle, Washington. Dr. Carlin is highly rated in 25 conditions, according to our data. His top areas of expertise are Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA), Scleroma, and Scleroderma.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Rheumatology

Licenses

Internal Medicine in WA

Hospital Affiliations

University Of Washington Medical Ctr

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO

Locations

Virginia Mason Medical Center
1100 9th Ave, Seattle, WA 98101

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2025
Intervention Type: Drug
Study Drug: Ifetroban
Study Phase: Phase 2
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: June 12, 2025
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Enrollment Status: Terminated
Publish Date: June 05, 2023
Intervention Type: Drug
Study Drug: Belumosudil
Study Phase: Phase 2
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 7 Less Clinical Trials

8 Total Publications

T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts.
T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts.
Journal: The Journal of investigative dermatology
Published: August 30, 2024
Similar Doctors
Philip J. Mease
Expertise in
10
conditions
Dr. Philip J. Mease
Rheumatology
Expertise in
10
conditions
Dr. Philip J. Mease
Rheumatology
601 Broadway, 
Seattle, WA 
 (3.0 miles away)
206-386-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Mease graduated from Stanford University receiving his Medical Doctorate. He specializes in internal medicine and rheumatology. Dr. Mease is a practicing physician at Seattle Rheumatology Associates, Swedish Cherry Hill, and Swedish First Hill. Dr. Mease is highly rated in 10 conditions, according to our data. His top areas of expertise are Psoriatic Arthritis, Arthritis, Psoriasis, and Axial Spondyloarthritis (AxSpA).

Vivian Stone
Expertise in
46
conditions
Dr. Vivian Stone
Rheumatology
Expertise in
46
conditions
Dr. Vivian Stone
Rheumatology

Virginia Mason Medical Center

1100 Ninth Avenue, 
Seattle, WA 
 (2.9 miles away)
206-624-1144
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Vivian Stone, MD, is a board-certified rheumatologist (arthritis doctor) with special medical interest in inflammatory arthritis, systemic lupus erythematosus (SLE) and connective tissue diseases. With all the new medications at hand that can reduce the damage these conditions inflict and improve quality of life, Dr. Stone feels it is an exciting time to be a rheumatologist.Dr. Stone enjoys keeping her patients healthy through preventive medicine and monitoring, which allows her to form long-term relationships with her patients. When a patient responds well to treatment, she is so gratified to have played a small part in helping to improve their quality of life.Dr. Stone was voted one of Seattle's Top Doctors bySeattle Metropolitanmagazine in 2019, 2020 and 2021.Away from work, she enjoys hiking and being outdoors. Dr. Stone is highly rated in 46 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Sjogren Syndrome, and Psoriatic Arthritis.

Amish J. Dave
Expertise in
23
conditions
Dr. Amish J. Dave
Rheumatology
Expertise in
23
conditions
Dr. Amish J. Dave
Rheumatology

Virginia Mason Medical Center

1100 Ninth Avenue, 
Seattle, WA 
 (2.9 miles away)
206-624-1144
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Amish Dave, MD, is a board-certified rheumatologist. He treats common conditions such as musculoskeletal concerns and sports injuries, as well as autoimmune diseases such as rheumatoid arthritis, lupus, psoriatic arthritis and vasculitis.Dr. Dave gets to know his patients and their families well, including who a patient's support people are, what symptoms they are experiencing, what barriers they have to treatment, what makes them feel both good and bad, and what their goals are. He finds it highly rewarding to see how treatment improves his patients' lives.Hear Dr. Dave talk about the Rheumatology Crisis. Dr. Dave is highly rated in 23 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Rheumatoid Vasculitis, Psoriasis, and Ankylosing Spondylitis.

Frequently Asked Questions about Dr. Jeffrey Carlin

How do I make an appointment with Dr. Jeffrey Carlin?

You can book an appointment with Dr. Jeffrey Carlin by calling their office at 206-223-6600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey Carlin a top-rated expert for Systemic Sclerosis (SSc)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey Carlin is classified as an Distinguished expert for Systemic Sclerosis (SSc), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey Carlin specialize in?

While Dr. Jeffrey Carlin is a Rheumatology, they have specific expertise in Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA), and Scleroma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Jeffrey Carlin participate in research or clinical trials?

Yes. Dr. Jeffrey Carlin has published 8 articles and abstracts on conditions like Systemic Sclerosis (SSc). You can view a list of Dr. Jeffrey Carlin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeffrey Carlin accept my insurance?

Dr. Jeffrey Carlin accepts most major insurance plans, including Cambia Health Solutions and Cigna. We recommend calling the office directly at 206-223-6600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carlin's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 18 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile